Although present at low levels in chronic phase, a higher variant allele frequency of TP53 mutations has been observed in post-MPN AML samples, suggesting loss of the wild-type TP53 allele contributes to clonal expansion40,41. This evidence concerns the gene TP53 and myeloproliferative neoplasm.